Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

Kulkarni S, Lied A, Kulkarni V, Rucevic M, Martin MP, Walker-Sperling V, Anderson SK, Ewy R, Singh S, Nguyen H, McLaren PJ, Viard M, Naranbhai V, Zou C, Lin Z, Gatanaga H, Oka S, Takiguchi M, Thio CL, Margolick J, Kirk GD, Goedert JJ, Hoots WK, Deeks SG, Haas DW, Michael N, Walker B, Le Gall S, Chowdhury FZ, Yu XG, Carrington M.

Nat Immunol. 2019 Jul;20(7):824-834. doi: 10.1038/s41590-019-0406-1. Epub 2019 Jun 17.

PMID:
31209403
2.

Interaction of the Host and Viral Genome and Their Influence on HIV Disease.

Tough RH, McLaren PJ.

Front Genet. 2019 Jan 23;9:720. doi: 10.3389/fgene.2018.00720. eCollection 2018. Review.

3.

HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control.

Arora J, McLaren PJ, Chaturvedi N, Carrington M, Fellay J, Lenz TL.

Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):944-949. doi: 10.1073/pnas.1812548116. Epub 2019 Jan 2.

4.

Are privacy-enhancing technologies for genomic data ready for the clinic? A survey of medical experts of the Swiss HIV Cohort Study.

Raisaro JL, McLaren PJ, Fellay J, Cavassini M, Klersy C, Hubaux JP; Swiss HIV Cohort Study.

J Biomed Inform. 2018 Mar;79:1-6. doi: 10.1016/j.jbi.2017.12.013. Epub 2018 Jan 10.

5.

Retroviruses As Myeloid Cell Riders: What Natural Human Siglec-1 "Knockouts" Tell Us About Pathogenesis.

Martinez-Picado J, McLaren PJ, Telenti A, Izquierdo-Useros N.

Front Immunol. 2017 Nov 21;8:1593. doi: 10.3389/fimmu.2017.01593. eCollection 2017.

6.

Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.

McLaren PJ, Pulit SL, Gurdasani D, Bartha I, Shea PR, Pomilla C, Gupta N, Gkrania-Klotsas E, Young EH, Bannert N, Del Amo J, Gill MJ, Gilmour J, Kellam P, Kelleher AD, Sönnerborg A, Zangerle R, Post FA, Fisher M, Haas DW, Walker BD, Porter K, Goldstein DB, Sandhu MS, de Bakker PIW, Fellay J.

J Infect Dis. 2017 Nov 27;216(9):1063-1069. doi: 10.1093/infdis/jix470. Erratum in: J Infect Dis. 2018 Jun 5;218(1):171.

7.

A39 Human exome sequencing to evaluate the impact of rare coding variation on HIV-1 control.

McLaren PJ, Shea PR, Bartha I, Fellay J.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.038. doi: 10.1093/ve/vew036.038. eCollection 2017 Mar. No abstract available.

8.

Paraesophageal Hernia Repair Outcomes Using Minimally Invasive Approaches.

McLaren PJ, Hart KD, Hunter JG, Dolan JP.

JAMA Surg. 2017 Dec 1;152(12):1176-1178. doi: 10.1001/jamasurg.2017.2868. No abstract available.

9.

Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.

Asgari S, Schlapbach LJ, Anchisi S, Hammer C, Bartha I, Junier T, Mottet-Osman G, Posfay-Barbe KM, Longchamp D, Stocker M, Cordey S, Kaiser L, Riedel T, Kenna T, Long D, Schibler A, Telenti A, Tapparel C, McLaren PJ, Garcin D, Fellay J.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8342-8347. doi: 10.1073/pnas.1704259114. Epub 2017 Jul 17.

10.

Laparoscopic ischemic conditioning of the stomach increases neovascularization of the gastric conduit in patients undergoing esophagectomy for cancer.

Pham TH, Melton SD, McLaren PJ, Mokdad AA, Huerta S, Wang DH, Perry KA, Hardaker HL, Dolan JP.

J Surg Oncol. 2017 Sep;116(3):391-397. doi: 10.1002/jso.24668. Epub 2017 May 29.

11.

Evolution in the Treatment of Esophageal Disease at a Single Academic Institution: 2004-2013.

Dolan JP, McLaren PJ, Diggs BS, Schipper PH, Tieu BH, Sheppard BC, Gilbert EW, Conroy MA, Hunter JG.

J Laparoendosc Adv Surg Tech A. 2017 Sep;27(9):915-923. doi: 10.1089/lap.2017.0069. Epub 2017 May 9.

12.

Specific gene expression profiles are associated with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinoma.

McLaren PJ, Barnes AP, Terrell WZ, Vaccaro GM, Wiedrick J, Hunter JG, Dolan JP.

Am J Surg. 2017 May;213(5):915-920. doi: 10.1016/j.amjsurg.2017.03.024. Epub 2017 Mar 27.

13.

Surgical Treatment of High-Grade Dysplasia and Early Esophageal Cancer.

McLaren PJ, Dolan JP.

World J Surg. 2017 Jul;41(7):1712-1718. doi: 10.1007/s00268-017-3958-y. Review.

PMID:
28258451
14.

Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control.

Bartha I, McLaren PJ, Brumme C, Harrigan R, Telenti A, Fellay J.

PLoS Comput Biol. 2017 Feb 9;13(2):e1005339. doi: 10.1371/journal.pcbi.1005339. eCollection 2017 Feb.

15.

No Evidence for Association of β-Defensin Genomic Copy Number with HIV Susceptibility, HIV Load during Clinical Latency, or Progression to AIDS.

Abujaber R, Shea PR, McLaren PJ, Lakhi S, Gilmour J, Allen S, Fellay J, Hollox EJ; IAVI Africa HIV Prevention Partnership, Swiss HIV Cohort Study.

Ann Hum Genet. 2017 Jan;81(1):27-34. doi: 10.1111/ahg.12182.

16.

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios can Predict Treatment Response to Neoadjuvant Therapy in Esophageal Cancer.

McLaren PJ, Bronson NW, Hart KD, Vaccaro GM, Gatter KM, Thomas CR Jr, Hunter JG, Dolan JP.

J Gastrointest Surg. 2017 Apr;21(4):607-613. doi: 10.1007/s11605-016-3351-4. Epub 2017 Jan 12.

PMID:
28083838
17.

Successful medical management of a domestic longhair cat with subdural intracranial empyema and multifocal pneumonia.

Cardy TJ, Lam R, Peters LM, McLaren PJ, Matas Riera M, De Decker S.

J Vet Emerg Crit Care (San Antonio). 2017 Mar;27(2):238-242. doi: 10.1111/vec.12566. Epub 2017 Jan 12.

PMID:
28079960
18.

Corrigendum: Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired Pseudomonas aeruginosa Sepsis.

Asgari S, McLaren PJ, Peake J, Wong M, Wong R, Bartha I, Francis JR, Abarca K, Gelderman KA, Agyeman P, Aebi C, Berger C, Fellay J, Schlapbach LJ; Swiss Pediatric Sepsis Study.

Front Immunol. 2016 Oct 27;7:447. eCollection 2016.

19.

What is your diagnosis? Peritoneal effusion in a 10-year-old horse.

McLaren PJ, Jocelyn NA.

Vet Clin Pathol. 2016 Dec;45(4):723-724. doi: 10.1111/vcp.12418. Epub 2016 Oct 23. No abstract available.

PMID:
27774632
20.

Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired Pseudomonas aeruginosa Sepsis.

Asgari S, McLaren PJ, Peake J, Wong M, Wong R, Bartha I, Francis JR, Abarca K, Gelderman KA, Agyeman P, Aebi C, Berger C, Fellay J, Schlapbach LJ; Swiss Pediatric Sepsis Study.

Front Immunol. 2016 Sep 20;7:357. eCollection 2016. Erratum in: Front Immunol. 2016 Oct 27;7:447.

21.

Esophagectomy as a Treatment Consideration for Early-Stage Esophageal Cancer and High-Grade Dysplasia.

McLaren PJ, Dolan JP.

J Laparoendosc Adv Surg Tech A. 2016 Oct;26(10):757-762. Epub 2016 Aug 19. Review.

PMID:
27541368
22.

Identification of Siglec-1 null individuals infected with HIV-1.

Martinez-Picado J, McLaren PJ, Erkizia I, Martin MP, Benet S, Rotger M, Dalmau J, Ouchi D, Wolinsky SM, Penugonda S, Günthard HF, Fellay J, Carrington M, Izquierdo-Useros N, Telenti A.

Nat Commun. 2016 Aug 11;7:12412. doi: 10.1038/ncomms12412.

23.

Plasmodium infection in a Leadbeater's possum (Gymnobelideus leadbeateri).

Scheelings TF, McLaren PJ, Tatarczuch L, Slocombe RF.

Aust Vet J. 2016 Aug;94(8):299-303. doi: 10.1111/avj.12466.

PMID:
27461356
24.

Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.

Lee SA, Mefford JA, Huang Y, Witte JS, Martin JN, Haas DW, Mclaren PJ, Mushiroda T, Kubo M, Byakwaga H, Hunt PW, Kroetz DL.

AIDS. 2016 Jul 17;30(11):1807-15. doi: 10.1097/QAD.0000000000001124.

25.

Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity.

Krapp C, Hotter D, Gawanbacht A, McLaren PJ, Kluge SF, Stürzel CM, Mack K, Reith E, Engelhart S, Ciuffi A, Hornung V, Sauter D, Telenti A, Kirchhoff F.

Cell Host Microbe. 2016 Apr 13;19(4):504-14. doi: 10.1016/j.chom.2016.02.019. Epub 2016 Mar 17.

26.

Privacy-preserving genomic testing in the clinic: a model using HIV treatment.

McLaren PJ, Raisaro JL, Aouri M, Rotger M, Ayday E, Bartha I, Delgado MB, Vallet Y, Günthard HF, Cavassini M, Furrer H, Doco-Lecompte T, Marzolini C, Schmid P, Di Benedetto C, Decosterd LA, Fellay J, Hubaux JP, Telenti A.

Genet Med. 2016 Aug;18(8):814-22. doi: 10.1038/gim.2015.167. Epub 2016 Jan 14.

27.

The Characteristics of Heterozygous Protein Truncating Variants in the Human Genome.

Bartha I, Rausell A, McLaren PJ, Mohammadi P, Tardaguila M, Chaturvedi N, Fellay J, Telenti A.

PLoS Comput Biol. 2015 Dec 7;11(12):e1004647. doi: 10.1371/journal.pcbi.1004647. eCollection 2015 Dec.

28.

Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.

McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, Buchbinder S, Carrington MN, Cossarizza A, Dalmau J, De Luca A, Goedert JJ, Gurdasani D, Haas DW, Herbeck JT, Johnson EO, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, Poli G, Sandhu MS, Schuitemaker H, Shea PR, Theodorou I, Walker BD, Weintrob AC, Winkler CA, Wolinsky SM, Raychaudhuri S, Goldstein DB, Telenti A, de Bakker PI, Zagury JF, Fellay J.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14658-63. doi: 10.1073/pnas.1514867112. Epub 2015 Nov 9.

29.

Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common Viruses.

Hammer C, Begemann M, McLaren PJ, Bartha I, Michel A, Klose B, Schmitt C, Waterboer T, Pawlita M, Schulz TF, Ehrenreich H, Fellay J.

Am J Hum Genet. 2015 Nov 5;97(5):738-43. doi: 10.1016/j.ajhg.2015.09.008. Epub 2015 Oct 8.

30.

The impact of host genetic variation on infection with HIV-1.

McLaren PJ, Carrington M.

Nat Immunol. 2015 Jun;16(6):577-83. doi: 10.1038/ni.3147. Review.

31.

Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses.

McLaren PJ, Gawanbacht A, Pyndiah N, Krapp C, Hotter D, Kluge SF, Götz N, Heilmann J, Mack K, Sauter D, Thompson D, Perreaud J, Rausell A, Munoz M, Ciuffi A, Kirchhoff F, Telenti A.

Retrovirology. 2015 May 16;12:41. doi: 10.1186/s12977-015-0165-5.

32.

Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.

Henrich TJ, McLaren PJ, Rao SS, Lin NH, Hanhauser E, Giguel F, Gulick RM, Ribaudo H, de Bakker PI, Kuritzkes DR.

Open Forum Infect Dis. 2014 May 22;1(1):ofu018. doi: 10.1093/ofid/ofu018. eCollection 2014 Mar.

33.

Human genetic variation in HIV disease: beyond genome-wide association studies.

McLaren PJ, Fellay J.

Curr Opin HIV AIDS. 2015 Mar;10(2):110-5. doi: 10.1097/COH.0000000000000133. Review.

PMID:
25522017
34.

A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.

Braun DL, Kouyos R, Oberle C, Grube C, Joos B, Fellay J, McLaren PJ, Kuster H, Günthard HF.

PLoS One. 2014 Dec 9;9(12):e114111. doi: 10.1371/journal.pone.0114111. eCollection 2014.

35.

Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.

Lehmann DS, Ribaudo HJ, Daar ES, Gulick RM, Haubrich RH, Robbins GK, de Bakker PI, Haas DW, McLaren PJ.

Pharmacogenet Genomics. 2015 Feb;25(2):51-9. doi: 10.1097/FPC.0000000000000106.

36.

Defining the role of common variation in the genomic and biological architecture of adult human height.

Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, Chu AY, Estrada K, Luan J, Kutalik Z, Amin N, Buchkovich ML, Croteau-Chonka DC, Day FR, Duan Y, Fall T, Fehrmann R, Ferreira T, Jackson AU, Karjalainen J, Lo KS, Locke AE, Mägi R, Mihailov E, Porcu E, Randall JC, Scherag A, Vinkhuyzen AA, Westra HJ, Winkler TW, Workalemahu T, Zhao JH, Absher D, Albrecht E, Anderson D, Baron J, Beekman M, Demirkan A, Ehret GB, Feenstra B, Feitosa MF, Fischer K, Fraser RM, Goel A, Gong J, Justice AE, Kanoni S, Kleber ME, Kristiansson K, Lim U, Lotay V, Lui JC, Mangino M, Mateo Leach I, Medina-Gomez C, Nalls MA, Nyholt DR, Palmer CD, Pasko D, Pechlivanis S, Prokopenko I, Ried JS, Ripke S, Shungin D, Stancáková A, Strawbridge RJ, Sung YJ, Tanaka T, Teumer A, Trompet S, van der Laan SW, van Setten J, Van Vliet-Ostaptchouk JV, Wang Z, Yengo L, Zhang W, Afzal U, Arnlöv J, Arscott GM, Bandinelli S, Barrett A, Bellis C, Bennett AJ, Berne C, Blüher M, Bolton JL, Böttcher Y, Boyd HA, Bruinenberg M, Buckley BM, Buyske S, Caspersen IH, Chines PS, Clarke R, Claudi-Boehm S, Cooper M, Daw EW, De Jong PA, Deelen J, Delgado G, Denny JC, Dhonukshe-Rutten R, Dimitriou M, Doney AS, Dörr M, Eklund N, Eury E, Folkersen L, Garcia ME, Geller F, Giedraitis V, Go AS, Grallert H, Grammer TB, Gräßler J, Grönberg H, de Groot LC, Groves CJ, Haessler J, Hall P, Haller T, Hallmans G, Hannemann A, Hartman CA, Hassinen M, Hayward C, Heard-Costa NL, Helmer Q, Hemani G, Henders AK, Hillege HL, Hlatky MA, Hoffmann W, Hoffmann P, Holmen O, Houwing-Duistermaat JJ, Illig T, Isaacs A, James AL, Jeff J, Johansen B, Johansson Å, Jolley J, Juliusdottir T, Junttila J, Kho AN, Kinnunen L, Klopp N, Kocher T, Kratzer W, Lichtner P, Lind L, Lindström J, Lobbens S, Lorentzon M, Lu Y, Lyssenko V, Magnusson PK, Mahajan A, Maillard M, McArdle WL, McKenzie CA, McLachlan S, McLaren PJ, Menni C, Merger S, Milani L, Moayyeri A, Monda KL, Morken MA, Müller G, Müller-Nurasyid M, Musk AW, Narisu N, Nauck M, Nolte IM, Nöthen MM, Oozageer L, Pilz S, Rayner NW, Renstrom F, Robertson NR, Rose LM, Roussel R, Sanna S, Scharnagl H, Scholtens S, Schumacher FR, Schunkert H, Scott RA, Sehmi J, Seufferlein T, Shi J, Silventoinen K, Smit JH, Smith AV, Smolonska J, Stanton AV, Stirrups K, Stott DJ, Stringham HM, Sundström J, Swertz MA, Syvänen AC, Tayo BO, Thorleifsson G, Tyrer JP, van Dijk S, van Schoor NM, van der Velde N, van Heemst D, van Oort FV, Vermeulen SH, Verweij N, Vonk JM, Waite LL, Waldenberger M, Wennauer R, Wilkens LR, Willenborg C, Wilsgaard T, Wojczynski MK, Wong A, Wright AF, Zhang Q, Arveiler D, Bakker SJ, Beilby J, Bergman RN, Bergmann S, Biffar R, Blangero J, Boomsma DI, Bornstein SR, Bovet P, Brambilla P, Brown MJ, Campbell H, Caulfield MJ, Chakravarti A, Collins R, Collins FS, Crawford DC, Cupples LA, Danesh J, de Faire U, den Ruijter HM, Erbel R, Erdmann J, Eriksson JG, Farrall M, Ferrannini E, Ferrières J, Ford I, Forouhi NG, Forrester T, Gansevoort RT, Gejman PV, Gieger C, Golay A, Gottesman O, Gudnason V, Gyllensten U, Haas DW, Hall AS, Harris TB, Hattersley AT, Heath AC, Hengstenberg C, Hicks AA, Hindorff LA, Hingorani AD, Hofman A, Hovingh GK, Humphries SE, Hunt SC, Hypponen E, Jacobs KB, Jarvelin MR, Jousilahti P, Jula AM, Kaprio J, Kastelein JJ, Kayser M, Kee F, Keinanen-Kiukaanniemi SM, Kiemeney LA, Kooner JS, Kooperberg C, Koskinen S, Kovacs P, Kraja AT, Kumari M, Kuusisto J, Lakka TA, Langenberg C, Le Marchand L, Lehtimäki T, Lupoli S, Madden PA, Männistö S, Manunta P, Marette A, Matise TC, McKnight B, Meitinger T, Moll FL, Montgomery GW, Morris AD, Morris AP, Murray JC, Nelis M, Ohlsson C, Oldehinkel AJ, Ong KK, Ouwehand WH, Pasterkamp G, Peters A, Pramstaller PP, Price JF, Qi L, Raitakari OT, Rankinen T, Rao DC, Rice TK, Ritchie M, Rudan I, Salomaa V, Samani NJ, Saramies J, Sarzynski MA, Schwarz PE, Sebert S, Sever P, Shuldiner AR, Sinisalo J, Steinthorsdottir V, Stolk RP, Tardif JC, Tönjes A, Tremblay A, Tremoli E, Virtamo J, Vohl MC; Electronic Medical Records and Genomics (eMEMERGEGE) Consortium; MIGen Consortium; PAGEGE Consortium; LifeLines Cohort Study, Amouyel P, Asselbergs FW, Assimes TL, Bochud M, Boehm BO, Boerwinkle E, Bottinger EP, Bouchard C, Cauchi S, Chambers JC, Chanock SJ, Cooper RS, de Bakker PI, Dedoussis G, Ferrucci L, Franks PW, Froguel P, Groop LC, Haiman CA, Hamsten A, Hayes MG, Hui J, Hunter DJ, Hveem K, Jukema JW, Kaplan RC, Kivimaki M, Kuh D, Laakso M, Liu Y, Martin NG, März W, Melbye M, Moebus S, Munroe PB, Njølstad I, Oostra BA, Palmer CN, Pedersen NL, Perola M, Pérusse L, Peters U, Powell JE, Power C, Quertermous T, Rauramaa R, Reinmaa E, Ridker PM, Rivadeneira F, Rotter JI, Saaristo TE, Saleheen D, Schlessinger D, Slagboom PE, Snieder H, Spector TD, Strauch K, Stumvoll M, Tuomilehto J, Uusitupa M, van der Harst P, Völzke H, Walker M, Wareham NJ, Watkins H, Wichmann HE, Wilson JF, Zanen P, Deloukas P, Heid IM, Lindgren CM, Mohlke KL, Speliotes EK, Thorsteinsdottir U, Barroso I, Fox CS, North KE, Strachan DP, Beckmann JS, Berndt SI, Boehnke M, Borecki IB, McCarthy MI, Metspalu A, Stefansson K, Uitterlinden AG, van Duijn CM, Franke L, Willer CJ, Price AL, Lettre G, Loos RJ, Weedon MN, Ingelsson E, O'Connell JR, Abecasis GR, Chasman DI, Goddard ME, Visscher PM, Hirschhorn JN, Frayling TM.

Nat Genet. 2014 Nov;46(11):1173-86. doi: 10.1038/ng.3097. Epub 2014 Oct 5.

37.

Disentangling human tolerance and resistance against HIV.

Regoes RR, McLaren PJ, Battegay M, Bernasconi E, Calmy A, Günthard HF, Hoffmann M, Rauch A, Telenti A, Fellay J; Swiss HIV Cohort Study.

PLoS Biol. 2014 Sep 16;12(9):e1001951. doi: 10.1371/journal.pbio.1001951. eCollection 2014 Sep.

38.

On stand by: host genetics of HIV control.

Carrington M, Bashirova AA, McLaren PJ.

AIDS. 2013 Nov 28;27(18):2831-9. doi: 10.1097/01.aids.0000432536.85335.c8. Review.

PMID:
25119688
39.

Analysis of stop-gain and frameshift variants in human innate immunity genes.

Rausell A, Mohammadi P, McLaren PJ, Bartha I, Xenarios I, Fellay J, Telenti A.

PLoS Comput Biol. 2014 Jul 24;10(7):e1003757. doi: 10.1371/journal.pcbi.1003757. eCollection 2014 Jul.

40.

HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1.

Izquierdo-Useros N, Lorizate M, McLaren PJ, Telenti A, Kräusslich HG, Martinez-Picado J.

PLoS Pathog. 2014 Jul 17;10(7):e1004146. doi: 10.1371/journal.ppat.1004146. eCollection 2014 Jul. Review.

41.

Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.

Fitzmaurice K, Hurst J, Dring M, Rauch A, McLaren PJ, Günthard HF, Gardiner C, Klenerman P; Irish HCV Research Consortium; Swiss HIV Cohort Study.

Gut. 2015 May;64(5):813-9. doi: 10.1136/gutjnl-2013-306287. Epub 2014 Jul 4.

42.

HLA class I and KIR genes do not protect against HIV type 1 infection in highly exposed uninfected individuals with hemophilia A.

Vince N, Bashirova AA, Lied A, Gao X, Dorrell L, McLaren PJ, Fellay J, Carrington M.

J Infect Dis. 2014 Oct 1;210(7):1047-51. doi: 10.1093/infdis/jiu214. Epub 2014 Apr 8.

43.

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.

Johnson DH, Venuto C, Ritchie MD, Morse GD, Daar ES, McLaren PJ, Haas DW.

Pharmacogenet Genomics. 2014 Apr;24(4):195-203. doi: 10.1097/FPC.0000000000000034.

44.

Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.

Leger PD, Johnson DH, Robbins GK, Shafer RW, Clifford DB, Li J, McLaren PJ, Haas DW.

J Neurovirol. 2014 Jun;20(3):304-8. doi: 10.1007/s13365-014-0235-9. Epub 2014 Feb 20.

45.

GuavaH: a compendium of host genomic data in HIV biology and disease.

Bartha I, McLaren PJ, Ciuffi A, Fellay J, Telenti A.

Retrovirology. 2014 Jan 15;11:6. doi: 10.1186/1742-4690-11-6.

46.

Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.

Cespedes MS, Kerns SL, Holzman RS, McLaren PJ, Ostrer H, Aberg JA.

HIV Clin Trials. 2013 Nov-Dec;14(6):292-302. doi: 10.1310/hct1406-292.

47.

A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.

Bartha I, Carlson JM, Brumme CJ, McLaren PJ, Brumme ZL, John M, Haas DW, Martinez-Picado J, Dalmau J, López-Galíndez C, Casado C, Rauch A, Günthard HF, Bernasconi E, Vernazza P, Klimkait T, Yerly S, O'Brien SJ, Listgarten J, Pfeifer N, Lippert C, Fusi N, Kutalik Z, Allen TM, Müller V, Harrigan PR, Heckerman D, Telenti A, Fellay J.

Elife. 2013 Oct 29;2:e01123. doi: 10.7554/eLife.01123.

48.

HIV and innate immunity - a genomics perspective.

Rausell A, McLaren PJ, Telenti A.

F1000Prime Rep. 2013 Aug 1;5:29. doi: 10.12703/P5-29. eCollection 2013.

49.

Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.

McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, O'Brien SJ, Pereyra F, Plummer FA, Poli G, Qi Y, Rucart P, Sandhu MS, Shea PR, Schuitemaker H, Theodorou I, Vannberg F, Veldink J, Walker BD, Weintrob A, Winkler CA, Wolinsky S, Telenti A, Goldstein DB, de Bakker PI, Zagury JF, Fellay J.

PLoS Pathog. 2013;9(7):e1003515. doi: 10.1371/journal.ppat.1003515. Epub 2013 Jul 25.

50.

Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid.

Rahm N, Gfeller D, Snoeck J, Martinez R, McLaren PJ, Ortiz M, Ciuffi A, Telenti A.

Virology. 2013 Jul 5;441(2):162-70. doi: 10.1016/j.virol.2013.03.021. Epub 2013 Apr 17.

Supplemental Content

Loading ...
Support Center